Ignite Creation Date:
2025-12-24 @ 7:57 PM
Ignite Modification Date:
2026-01-25 @ 3:15 AM
Study NCT ID:
NCT01801904
Status:
UNKNOWN
Last Update Posted:
2023-03-24
First Post:
2013-01-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 2 Study of Panitumumab in Patients With Cetuximab-refractory Metastatic Colorectal Cancer
Sponsor:
National Cancer Institute, Naples
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-12
Start Date Type:
None
Primary Completion Date:
2024-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-12
Completion Date Type:
ESTIMATED
First Submit Date:
2013-01-15
First Submit QC Date:
None
Study First Post Date:
2013-03-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-03-23
Last Update Post Date:
2023-03-24
Last Update Post Date Type:
ACTUAL